Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

计划入组 50 人 · 首次发布于 2004 年 11 月 9 日

Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease

计划入组 90 人 · 首次发布于 2005 年 7 月 29 日

sing N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson’s Disease

计划入组 44 人

neuroprotectants (Parkinson’s disease)

Parkinson’s Disease(Nitrase)

drug candidate (Parkinson’s disease)

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

Parkinson's Disease Research Focuses on Disease-Modifying Therapies

MapLight Therapeutics Receives FDA Fast Track Designation for Alzheimer's Disease Psychosis Treatment

Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis